Physician profile
Spencer Corbin
NPI 1033794532
$534.30
in general payments reported to CMS, 2019-2025
11 companies · $239 in 2025
The $239 reported for 2025 was more than what 90% of Chiropractor providers received nationally (typical 2025 total: $40.91).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $161 · 2023: $118 · 2024: $15.95 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $372.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $149.83 | 2022-2023 | Seglentis |
| Ucb, INC. | $91.41 | 2022-2025 | Bimzelx, Cimzia |
| Zimmer Biomet Holdings, INC. | $73.07 | 2025 | Totalshield |
| Vertex Pharmaceuticals Incorporated | $59.93 | 2025 | |
| Medtronic, INC. | $44.42 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $30.90 | 2023-2025 | Exparel, Zilretta, Iovera |
| Depuy Synthes Sales INC. | $22.03 | 2025 | Orthovisc, Monovisc |
| Seapearl East, INC | $21.06 | 2025 | |
| International Rehabilitative Sciences, INC | $15.95 | 2024 | Rs 4i Plus Sequential Stimulator |
| Sanofi-Aventis U.S. LLC | $15.04 | 2023 | |
| Electronic Waveform Lab, INC. | $10.66 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spencer Corbin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.